Viramune (Nevirapine) – Patient-Friendly Medicine Guide (UK)

Viramune is a brand name for nevirapine, an antiretroviral medicine used to treat Human Immunodeficiency Virus (HIV). It belongs to a group of medicines called non-nucleoside reverse transcriptase inhibitors (NNRTIs). This guide explains how Viramune works, how it behaves in the body, what it is used for, and practical advice on taking it safely in the United Kingdom.

If you have questions about your own treatment, always follow the plan provided by your healthcare team. Your regimen is tailored to your individual situation and may include other HIV medicines.

1. Basic Product Information

2. How Viramune Works (Mechanism of Action)

HIV relies on an enzyme called reverse transcriptase to copy its genetic material inside human cells. Viramune (nevirapine) blocks this enzyme by binding to it and preventing HIV from producing the DNA it needs to replicate. Because nevirapine interferes with the replication process, it helps reduce HIV levels in the body.

Viramune is used as part of a combination regimen. Using more than one antiretroviral medicine helps reduce the chance of HIV developing resistance.

3. Pharmacokinetics: What Happens to the Medicine in the Body

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. The following points help explain why monitoring is important and why dosing schedules matter.

• Absorption: Nevirapine is absorbed after oral dosing. Steady levels build up as treatment continues, which is why an initial “starter” period is often used.
• Distribution: Nevirapine distributes throughout the body, including across biological barriers.
• Metabolism: Nevirapine is mainly metabolised in the liver. This is one reason liver safety is a major focus.
• Elimination: Nevirapine and its metabolites are eliminated from the body primarily via the liver and kidneys.
• Drug levels & interactions: Nevirapine can affect the metabolism of other medicines and may interact with drugs that rely on liver enzymes.

4. Typical Use in HIV Treatment

Viramune (nevirapine) is used to treat HIV infection. In clinical practice in the UK, it is typically used in combination with other antiretroviral medicines. The choice of regimen depends on:

• your treatment history
• your current HIV viral load and immune status
• potential drug interactions
• test results for liver function
• other health conditions, including hepatitis infections

In general, nevirapine is not taken alone for HIV. Combination therapy helps keep viral replication suppressed.

5. Indications (When Viramune May Be Used)

In the UK, nevirapine is indicated for the treatment of HIV-1 infection in adults and children, depending on the specific product information and clinical guidance. It is typically used when a suitable combination of medicines can be provided to achieve viral suppression.

Your prescriber will consider whether nevirapine is appropriate for your circumstances, including your liver health, co-infections (such as hepatitis B or C), and the medicines you take.

6. Dosing and Timing (General Guidance)

Dosing must be individualised. The information below gives a general overview of dosing principles for nevirapine. Always follow the exact instructions provided for your product and regimen.

6.1 Starter period (“titration”) is important

Nevirapine regimens often begin with a lower dose for the first period of treatment, then increase to the full dose. This approach helps reduce the risk of adverse reactions, particularly during the early weeks.

6.2 Typical schedule

• Initial phase: usually a once-daily dose for a short period (commonly 14 days, depending on local guidance and individual factors).
• Ongoing phase: usually a twice-daily dose thereafter.

The exact doses depend on age, weight (for children), formulation, and clinical factors. Do not change your dose on your own.

6.3 What to do if you miss a dose

If you miss a dose, take it as soon as you remember unless it is close to the time for the next dose. Do not double up to make up for a missed dose. If you miss multiple doses or you have had a break, seek advice from your healthcare team before restarting, because restarting after interruption may require reassessment.

7. Food Interactions and Taking with Meals

Nevirapine can generally be taken with or without food. Taking it with food may improve tolerance if you experience stomach discomfort.

• Try to be consistent: taking it similarly each day can help you remember and may reduce stomach upset.
• Liquid formulation: if you use an oral suspension, shake well (if instructed on the label) and measure carefully using a proper device.

If you experience nausea, take the medicine with a meal or snack and discuss options with your clinician/pharmacist.

8. Alcohol and Medicine Interactions

8.1 Alcohol

Alcohol may increase the burden on the liver. Because nevirapine is processed primarily in the liver and can rarely cause serious liver reactions, it is generally wise to limit alcohol during treatment. If you have any history of liver disease, hepatitis, or elevated liver enzymes, seek medical advice promptly.

8.2 Interactions with other medicines

Some medicines can significantly change how nevirapine works or increase the risk of side effects. This is especially important for medicines that affect liver enzymes (for example, cytochrome P450 pathways).

Tell your healthcare team about all medicines you take, including:

• prescription medicines
• over-the-counter medicines
• herbal products and supplements
• recreational substances

Examples of medicines that may interact:

• Rifampicin (used for tuberculosis) and other strong enzyme inducers may reduce nevirapine levels, risking treatment failure.
• St John’s wort (a herbal remedy) may reduce HIV medicine levels through enzyme induction. Avoid unless your clinician specifically advises otherwise.
• Some anticonvulsants may alter levels of nevirapine.
• Hormonal contraceptives may have changed effectiveness depending on the regimen and individual factors. Discuss contraception options with your clinic.
• Anticoagulants and other medicines processed by the liver may require monitoring.

This is not a complete list. Your pharmacist can help check interactions with your specific medicines.

9. Safety Profile: Important Risks and When to Seek Help

Most people tolerate antiretroviral medicines well, but nevirapine has important potential side effects. The most notable concern is liver toxicity, especially within the first few weeks of treatment.

9.1 Liver problems (key warning)

Serious liver reactions can occur. Risk may be higher during the initial titration period and may be related to factors such as baseline liver health, co-infections, alcohol intake, and certain demographic factors.

Get urgent medical help if you notice:

• yellowing of the skin or eyes (jaundice)
• dark urine
• severe tiredness or weakness that is unusual for you
• loss of appetite, nausea, or persistent vomiting
• upper abdominal pain (especially right-sided discomfort)
• general feeling of being unwell with flu-like symptoms
• itching, especially if new or severe

Routine blood tests are used to monitor liver enzymes and overall safety. Do not skip scheduled monitoring appointments.

9.2 Rash and hypersensitivity reactions

Skin rash can occur. Severe rashes (including blistering, peeling, or involvement of eyes/mouth) require urgent attention. Stop and seek medical advice immediately if rash is accompanied by fever, swelling, or breathing difficulties.

9.3 Other possible side effects

• headache
• nausea, diarrhoea, or abdominal discomfort
• fatigue
• changes in blood tests (for example, liver enzymes)
• in some cases, increased risk of immune reconstitution inflammatory syndrome (IRIS) as HIV improves (varies by individual)

9.4 Special populations

• People with hepatitis B or C: extra caution and close monitoring are needed.
• People with pre-existing liver disease: discuss risks and monitoring carefully.
• Pregnancy: HIV treatment decisions are complex. If pregnant or planning pregnancy, talk to your HIV team as early as possible.
• Children: dosing depends on weight and requires careful monitoring.

10. Practical Use Tips for Safer, Easier Treatment

• Keep track of the starter schedule: do not jump to the full dose early without advice. The timing of the dose increase is part of the safety approach.
• Attend monitoring appointments: liver blood tests are essential, particularly during the first months.
• Use a daily reminder: phone alarms or pill boxes can reduce missed doses.
• Report new symptoms early: rash, fatigue, or jaundice should be discussed promptly.
• Check interactions before starting new medicines: including antibiotics, painkillers, acid reducers, and supplements.
• Maintain adherence: stopping suddenly or missing doses for prolonged periods can increase the risk of resistance.
• Hydration and nutrition: if you experience stomach upset, try taking with food and maintain regular meals.

11. Alternative Options (Other HIV Medicines)

There are several antiretroviral medicines available in the UK, including other NNRTIs and medicines from different classes such as integrase inhibitors and protease inhibitors. The “best” alternative depends on:

• your HIV history and resistance profile
• co-morbidities (especially liver and kidney conditions)
• potential interactions with your current medicines
• pregnancy plans and other individual factors

Common alternatives may include:

• Integrase inhibitors (often preferred in many modern regimens due to safety and convenience profiles)
• Other NNRTIs (chosen based on interaction and tolerability considerations)
• Protease inhibitors (sometimes used where specific reasons apply)

Do not switch HIV medicines without guidance. If you are considering alternatives because of side effects or interactions, discuss options with your HIV clinic.

12. UK Market and Legal/Clinical Context

In the United Kingdom, Viramune (nevirapine) is regulated as a prescription medicine and is used within established HIV care pathways. Availability, prescribing practice, and preferred regimens may change over time as newer antiretroviral options are adopted.

HIV treatment in the UK is guided by national and international standards of care and by specialist HIV services. Clinicians consider drug resistance patterns, patient safety, comorbidities, and monitoring requirements when selecting therapy.

12.1 Recent guidance (overview)

UK and international HIV guidance has evolved over the years to prioritise regimens with strong efficacy, tolerability, and convenient dosing. For many people, modern combination regimens may be preferred over older options, depending on individual circumstances such as resistance history and prior exposure.

Nevirapine may still be used in specific situations where it fits clinical needs. Safety monitoring, particularly for liver toxicity, remains a central part of care where nevirapine is used.

13. Delivery and Availability in the UK

Availability can vary depending on supply and formulation. If you order from a UK online pharmacy, delivery options typically include standard and express services (where available). Processing times depend on prescription verification procedures and stock status.

• Stock status: check the product listing for real-time availability if provided.
• Delivery times: may vary by postcode and carrier.
• Cold chain: nevirapine is not usually a temperature-controlled medicine, but always follow storage instructions on the packaging.
• Returns: healthcare medicines typically have restrictions on returns; follow the pharmacy’s policy.

If you need urgent continuity of treatment, contact the pharmacy as soon as possible so they can help arrange the fastest option.

14. Storage and Handling

• Store at the temperature stated on the label (often “store below 25°C”, but check your packaging).
• Keep in the original container to protect from light and moisture.
• Keep away from children.
• For oral suspensions: follow instructions on shaking, use-after-opening, and expiry.

15. FAQ – Frequently Asked Questions

Can I take Viramune with food?

Yes. Nevirapine can usually be taken with or without food. If it upsets your stomach, taking it with a meal may help.

Why do I start on a lower dose before increasing?

The starter dose helps reduce the risk of certain side effects, especially early in treatment. Always follow the titration schedule provided for your regimen.

What blood tests will I need?

Your clinic will typically monitor liver function and other safety parameters. The frequency is usually higher during the first weeks to months.

What should I do if I develop a rash?

Mild rashes should still be discussed promptly, but seek urgent help if the rash is severe, blistering, involves the mouth/eyes, or comes with fever or breathing difficulty.

Is alcohol safe while taking nevirapine?

It’s generally recommended to limit alcohol, particularly because nevirapine can affect the liver. If you have liver disease or hepatitis, seek advice before drinking.

How do I avoid drug interactions?

Provide a full list of your medicines and supplements to your pharmacist or clinic. Avoid starting new OTC medicines or herbal products without checking first.

Can I stop Viramune if I feel better?

Do not stop treatment without specialist guidance. Stopping or interrupting antiretrovirals can lead to viral rebound and resistance.

Are there alternatives if nevirapine isn’t suitable?

Yes. Other antiretroviral medicines and combination regimens may be suitable depending on your situation, resistance profile, and side-effect history. Discuss options with your HIV team.

How long does it take to work?

HIV viral load can drop quickly after effective therapy begins, but the timeline varies. Your clinic will check response using blood tests over time.

Where can I get more help in the UK?

Your HIV clinic or specialist pharmacist can help with questions about side effects, monitoring, and interactions. If you have symptoms suggesting liver problems or a severe rash, seek urgent medical advice.

Key Takeaways

• Viramune (nevirapine) is an NNRTI used in combination regimens to treat HIV.
• Liver monitoring is essential, especially during the first weeks of therapy.
• Follow the starter titration schedule and attend blood tests.
• Check interactions with all medicines and herbal products.
• Seek urgent help for signs of serious rash or liver problems.

This webpage is intended as general patient information for residents in the United Kingdom. It does not replace advice from your healthcare team or the official product information supplied with your medicine.